Schedule 13G ownership disclosure

Xeris Biopharma Holdings Inc

Security class unavailable · CUSIP: 98422E103

Event date: 2022-01-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,491,099
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-22-000016
Form type
SC 13G
Filer
Stonepine Capital Management, LLC
CIK
CIK 1440771
Filed
Jan 14, 2022
Reporting period
Jan 07, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub